dc.contributor.author | Butters, D | |
dc.contributor.author | Whitehouse, M | |
dc.date.accessioned | 2020-12-18T00:09:05Z | |
dc.date.available | 2020-12-18T00:09:05Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 0925-4692 | |
dc.identifier.doi | 10.1007/s10787-020-00774-8 | |
dc.identifier.uri | http://hdl.handle.net/10072/400353 | |
dc.description.abstract | The nutritional status of a patient can be critical for the efficacy of other pharmaceuticals, especially organic antibiotics, to treat viral pandemics. There may be political and scientific difficulties in achieving a constructive synergy of nutritional and prescribed allopathic remedies. For adequate treatment, timelines may need to extend well beyond eliminating viral proliferation, e.g., with vaccines, to include the goals of (a) reducing post-viral fatigue, (b) promoting earliest recovery, and (c) future resistance in often poorly nourished patients, e.g., obese (!). Many trace minerals (TM) and vitamins may need to be replenished. This review focusses only upon zinc to illustrate some problems in rectifying these TM deficiencies affecting the balance between continued ill-health (‘illth’) or regaining optimal physical and mental wellbeing. Ultimately, this is a matter of behaviour, lifestyle, and informed choice(s). See Hetzel and McMichael 1959.
“Epidemics are no accidents. A new pathogen will enter a community only when the conditions are ripe for it..”
Nathan Clumek, Brussels (Cribb 1996). | |
dc.description.peerreviewed | Yes | |
dc.language | English | |
dc.language.iso | eng | |
dc.publisher | Springer Science and Business Media LLC | |
dc.relation.ispartofjournal | Inflammopharmacology | |
dc.subject.fieldofresearch | Pharmacology and pharmaceutical sciences | |
dc.subject.fieldofresearchcode | 3214 | |
dc.subject.keywords | Drug-nutrient synergy | |
dc.subject.keywords | Hydroxychloroquine | |
dc.subject.keywords | Ivermectin | |
dc.subject.keywords | Post-viral fatigue | |
dc.subject.keywords | SARS-2 | |
dc.title | COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials | |
dc.type | Journal article | |
dc.type.description | C1 - Articles | |
dcterms.bibliographicCitation | Butters, D; Whitehouse, M, COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials, Inflammopharmacology, 2020 | |
dcterms.dateAccepted | 2020-10-25 | |
dc.date.updated | 2020-12-18T00:07:36Z | |
gro.description.notepublic | This publication has been entered as an advanced online version in Griffith Research Online. | |
gro.hasfulltext | No Full Text | |
gro.griffith.author | Whitehouse, Michael | |